Brief: Tracon Pharma Reports First Quarter 2023 Financial Results
10/05/2023 21:24
May 10 (Reuters) - Tracon Pharmaceuticals Inc TCON.O :
* TRACON PHARMACEUTICALS REPORTS FIRST QUARTER 2023
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* QTRLY LOSS PER SHARE $0.36
* Q1 EARNINGS PER SHARE VIEW $-0.26 -- REFINITIV IBES DATA
* CASH AND CASH EQUIVALENTS WERE $6.6 MILLION AT MARCH 31,
2023
Source text for Eikon: ID:nGNX7p5FrV
Further company coverage: TCON.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TRACON Pharmaceuticals
See all newsBrief: TRACON Pharmaceuticals Says ENVASARC Trial ORR Is 5%, Does Not Meet 11% Endpoint
Tracon Pharmaceuticals Inc Reports Results For The Quarter Ended In March: Earnings Summary
Tracon Pharmaceuticals Inc Expected To Post A Loss Of $1.19 A Share: Earnings Preview
Tracon Pharmaceuticals Inc Expected To Post A Loss Of $1.19 A Share: Earnings Preview
Brief: Tracon Pharmaceuticals Files For Offering Of Common Stock, Pre-Funded Warrants